M.-P. Heck, C. Matt, A. Wagner, L. Toupet, C. Mioskowski
2970, 2873, 1466, 1387, 1369, 1223, 1117, 1065, 1041, 980,
FULL PAPER
5-Isopropyl-2,3-dimethylcyclopent-2-enone (14b): From trans-2-
methyl-2-butenal (0.46 mL, 4.8 mmol), 3-methylbutyraldehyde 759 cm–1. MS (EI): m/z = 278, 235, 199, 198, 165, 163, 157, 127,
(0.51 mL, 4.8 mmol), and dibromotriphenylphosphorane (2 g,
4.8 mmol) in CH2Cl2 (3.2 mL), the crude cyclopentenone 14b was
obtained following the general procedure B. Purification by column
chromatography (hexane/Et2O, 8:2) afforded 14b (183 mg, 25%
yield) as a colorless oil. 1H NMR (200 MHz, CDCl3): δ = 2.52–
2.18 [m, 4 H, (CH3)2CH-CH, (CH3)2CH-CH, CHHЈ], 2.05 [s, 3 H,
=C(CH3)-C=O], 1.69 [s, 3 H, CHHЈ=C(CH3)], 0.94 [d, J = 7.8 Hz,
3 H, (CH3)(CH3)CH], 0.68 [d, J = 6.6 Hz, 3 H, (CH3)(CH3)
CH] ppm. 13C NMR (50 MHz, CDCl3): δ = 211.4, 168.8, 136.5,
97, 85, 72, 43. C12H23BrO2 (279.21): calcd. C 51.62, H 8.30; found
C 51.49, H 8.39.
1
Major diastereoisomer 16ab: M.p. 58 °C[24]. H NMR (400 MHz,
3
CDCl3): δ = 3.88 [d, J = 7.2 Hz, 1 H, (CH3)2C-CH-OH], 3.49 [d,
3J = 7.6 Hz, 1 H, -O-CH-C(CH3)2Br], 3.15 [d, 3J = 7.2 Hz, 1 H,
(CH3)2CH-CH-O-], 1.90–1.85 (br. s, 1 H, OH), 1.81 [s, 3 H,
CBr(CH3)(CH3)], 1.79–1.77 [br. s, 1 H, (CH3)2CH], 1.78 [s, 3 H,
CBr(CH3)(CH3)], 1.11 [s, 3 H, C(CH3)(CH3)], 1.00 [d, 3J = 6.4 Hz,
3 H, (CH3)(CH3)CH], 0.96 [s, 3 H, C(CH3)(CH3)], 0.88 [d, 3J =
6.8 Hz, 3 H, (CH3)(CH3)CH] ppm. 13C NMR (50 MHz, CDCl3): δ
= 90.9, 86.2, 81.7, 69.2, 44.3, 31.6, 29.8, 29.2, 23.9, 21.0, 18.5,
50.6, 46.7, 33.8, 28.5, 20.7, 16.9, 7.7 ppm. IR (neat): ν = 2957, 1698,
˜
1650, 1465, 1387, 1328, 1185, 1065 cm–1. MS (DCI/NH3): m/z =
153 [MH]+, 170 [MNH4]+. C10H16O (152.23): calcd. C 78.90, H
10.59; found C 78.75, H 10.55.
14.1 ppm. IR (neat): ν = 2970, 2873, 1466, 1387, 1369, 1223, 1117,
˜
1065, 1041, 980, 759 cm–1. MS (EI): m/z = 278, 235, 199, 198, 165,
163, 157, 127, 97, 85, 72, 43. C12H23BrO2 (279.21): calcd. C 51.62,
H 8.30; found C 51.46, H 8.33.
3,5-Dimethyl-2-pentylcyclopent-2-enone (14c): From 2-methyloct-2-
enal (84 mg, 0.6 mmol), propionaldehyde (43 µL, 0.6 mmol), and
dibromotriphenylphosphorane (253 mg, 0.6 mmol) in CH2Cl2
(1.2 mL), the crude cyclopentenone 14c was obtained following the
general procedure B. Silica gel chromatography (hexane/Et2O, 8:2)
afforded 14c (22 mg, 20% yield) as a colorless oil. 1H NMR
(200 MHz, CDCl3): δ = 2.73 (dd, 2J = 18.2, 3J = 7.2 Hz, 1 H,
CHHЈ), 2.32 (q, J = 7.2 Hz, 1 H, CHHЈ), 2.14 (m, 3 H, CH3-CH,
CH3-CH2-C=), 2.02 (s, 3 H, =C-CH3), 1.29 [m, 6 H, CH3(CH2)3-
CCDC-735049 (for 16ab) contains the supplementary crystallo-
graphic data for this paper. These data can be obtained free of
charge from The Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/data_request/cif.
2-(1-Bromo-1-methylpropyl)-5-sec-butyl-4-ethyl-4-methyltetrahydro-
furan-3-ol (16b): From 2-methylbutyraldehyde (0.43 mL, 4 mmol)
and dibromotriphenylphosphorane (1.69 g, 4 mmol) in CH2Cl2
(3 mL), the crude 16b was obtained following the general procedure
A. Purification by silica gel chromatography (hexane/EtOAc,
8.5:1.5) afforded a mixture of inseparable diastereoisomers 16b
(236 mg, 55 % yield) as a colorless oil. 1H NMR (400 MHz,
CDCl3): δ = 3.82 [d, 3J = 5.4 Hz, 1 H, (CH3)(C2H5)C-CH-OH],
3.61 [d, 3J = 6.2, 1 H, -O-CH-CBr(CH3)(C2H5)], 3.32 [d, 3J =
6.0 Hz, 1 H, (CH3)(C2H5)CH-CH-O-], 3.27–3.20 (m, 1 H, OH),
1.98–1.90 [m, 2 H, CBr(CH3 )(CH3 CH2 )], 1.69 [s, 3 H,
CBr(CH3)(CH3CH2)], 1.68–1.62 [br. s, 1 H, (CH3)(C2H5)CH-],
1.54–1.47 [m, 2 H, (CH3)(CH3CH2)CH-], 1.15–1.05 [m, 2 H,
(CH3)C(CH2CH3)], 1.09 [t, 3J = 7.1 Hz, 3 H, CBr(CH3)(CH3CH2)],
1.05–0.90 [m, 9 H, (CH3)(C2H5)CH-, (CH3)C(CH2CH3), (CH3)-
C(CH2CH3)], 0.88 [t, 3J = 7.0 Hz, 3 H, (CH3)(CH3CH2)CH-] ppm.
13C NMR (100 MHz, CDCl3): δ = 91.4, 90.9, 86.9, 86.5, 79.0, 73.1,
3
3
CH2], 1.14 (d, J = 7.4 Hz, 3 H, CH-CH3), 0.86 [t, J = 6.7 Hz, 3
H, CH3(CH2)3-CH2] ppm. 13C NMR (50 MHz, CDCl3): δ = 212.1,
168.1, 139.4, 40.6, 39.5, 31.7, 28.0, 22.9, 22.4, 17.0, 16.6, 14.0 ppm.
IR (neat): ν = 2959, 2929, 2857, 1699, 1648, 1457, 1385, 1233, 1096,
˜
978, 806, 667, 533 cm–1. MS (DCI/NH3): m/z = 181 [MH]+.
C12H20O (180.29): calcd. C 79.94, H 11.18; found C 79.74, H 11.06.
5-Ethyl-3-methylcyclopent-2-enone (14d): From methacrolein
(0.46 mL, 5.55 mmol), butyraldehyde (0.5 mL, 5.55 mmol), and di-
bromotriphenylphosphorane (2.34 g, 5.55 mmol) in CH2Cl2
(3.7 mL), the crude cyclopentenone 14d was obtained following the
general procedure B. Silica gel chromatography (hexane/Et2O, 8:2)
afforded 14d (456 mg, 66% yield) as a colorless oil. 1H NMR
(200 MHz, CDCl3): δ = 5.86 (d, J = 1.4 Hz, 1 H, =CH-C=O), 2.70
(dd, 2J = 18.3, 3J = 6.2 Hz, 1 H, CHHЈ), 2.26 (m, 1 H, CHHЈ),
2.09 (s, 3 H, =C-CH3), 1.77 (m, 1 H, CH3CH2-CH), 1.33 (m, 2
H, CH3CH2), 0.89 (t, J = 7.3 Hz, 3 H, CH3CH2) ppm. 13C NMR
(50 MHz, CDCl3): δ = 211.2, 177.4, 129.7, 47.6, 38.9, 23.9, 19.1,
47.2, 35.9, 34.1, 30.1, 27.6, 25.2, 16.3, 15.8, 10.9 ppm. IR (neat): ν
˜
= 3461, 2968, 2937, 2878, 1458, 1381, 1064, 1004, 787 cm–1. MS
(DCI/NH3): m/z = 241, 258, 338 [M(79Br) + NH4]+, 340 [M(81Br)
+ NH4]+. C15H29BrO2 (321.29): calcd. C 56.07, H 9.10; found C
56.29, H 9.03.
11.0 ppm. IR (neat): ν = 3433, 2962, 2933, 2874, 1696, 1624, 1461,
˜
1431, 1379, 1324, 1287, 1174, 1102, 1051, 966, 838 cm–1. MS (DCI/
NH3): m/z = 125 [MH]+, 142 [MNH4]+.
2-(1-Bromo-1-ethylpropyl)-4,4-diethyl-5-(1-ethylpropyl)tetrahydro-
furan-3-ol (16c): From 2-ethylbutyraldehyde (0.62 mL, 5 mmol) and
dibromotriphenylphosphorane (2.11 g, 5 mmol) in CH2Cl2 (5 mL),
the crude 16c was obtained following the general procedure A. Pu-
rification by silica gel chromatography (hexane/Et2O, 8:2) afforded
a mixture of inseparable diastereoisomers 16c (351 mg, 58% yield)
2-(1-Bromo-1-methylethyl)-5-isopropyl-4,4-dimethyltetrahydrofuran-
3-ol (16aa and 16ab): From 2-methylpropionaldehyde (0.44 mL,
4.82 mmol) and dibromotriphenylphosphorane (2.05 g, 4.82 mmol)
in CH2Cl2 (3.3 mL), the crude 16a was obtained following the gene-
ral procedure A. Purification by silica gel chromatography (hexane/
Et2O, 8.5:1.5) afforded two major separable diastereoisomers 16aa
and 16ab: minor diastereoisomer 16aa (50 mg, 10% yield) as a col-
orless oil and major diastereoisomer 16ab (266 mg, 60% yield) as
a white solid.
1
3
as an orange oil. H NMR (200 MHz, CDCl3): δ = 3.96 [d, J =
6.3 Hz, 1 H, (C2H5)2C-CH-OH], 3.61 [d, 3J = 4.3 Hz, 1 H, -O-CH-
CBr(C2H5)2], 3.51 [d, J = 6.3 Hz, 1 H, (C2H5)2CH-CH-O-], 2.11–
3
1.92 [m, 4 H, OH, (C2H5)2CH-, CBr(C2H5)(CH3CH2)], 1.61–1.29
[m, 10 H, 5(CH3)(CH2)], 1.07–0.81 [m, 18 H, 6(CH3)(CH2)] ppm.
13C NMR (50 MHz, CDCl3): δ = 87.0, 86.3, 80.2, 49.4, 40.5, 40.1,
31.6, 31.7, 30.7, 24.6, 24.2, 23.5, 23.0, 20.8, 11.4, 10.9, 9.5 ppm. IR
Minor diastereoisomer 16aa: 1H NMR (400 MHz, CDCl3): δ =
3
3
3.67 [d, J = 5.2 Hz, 1 H, (CH3)2C-CH-OH], 3.39 [d, J = 5.6 Hz,
1 H, -O-CH-C(CH3)2Br], 3.10 [d, 3J = 9.2 Hz, 1 H, (CH3)2CH-CH-
O-], 1.82 [s, 3 H, CBr(CH3)(CH3)], 1.79 [s, 3 H, CBr(CH3)(CH3)],
1.81–1.78 [br. s, 1 H, (CH3)2CH], 1.63–1.55 (br. s, 1 H, OH), 1.07
(neat): ν = 3515, 2965, 2878, 1460, 1381, 1109, 1070, 839, 557 cm–1.
˜
MS (DCI/NH3): m/z = 380 [M(79Br)NH4]+, 382 [M(81Br)NH4]+.
C18H35BrO2 (363.37): calcd. C 59.50, H 9.71; found C 59.40, H
9.61.
3
[s, 3 H, C(CH3)(CH3)], 1.01 [d, J = 7.1 Hz, 3 H, (CH3)(CH3)CH],
0.99 [s, 3 H, C(CH3)(CH3)], 0.92 [d, J = 6.8 Hz, 3 H, (CH3)(CH3)
CH] ppm. 13C NMR (50 MHz, CDCl3): δ = 91.7, 91.5, 82.9, 66.0,
3-(1-Bromocyclohexyl)-1-cyclohexyl-2-oxaspiro[4.5]decan-4-ol (16d):
43.9, 31.9, 29.5, 28.8, 22.16, 21.2, 21.15, 19.3 ppm. IR (neat): ν =
From cyclohexanecarbaldehyde (0.6 mL, 5 mmol) and dibromotri-
˜
970
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 966–971